semaglutide cardiovascular outcomes of and tirzepatide for patients with type 2 diabetes in clinical practice Real-World Study: Semaglutide Lowers Cardiovascular

Pharmacies await supply, yet the approval signals future price competition and broader access

It is important to note that whilst constipation is common, it does not affect all patients, and individual responses vary considerably

Swapping soda for water, adding an extra 10 minutes of walking each day, or getting more sleep can have a real impact over time

So I talked it over with my partner and decided to stay on a maintenance dose

According to Eli Lillys press release on November 6, 2025, starting as early as April 1, 2026, Medicare beneficiaries will pay no more than $50 per month for Zepbound (tirzepatide). Get Your Free GLP-1 Quick Start Action Plan Monitor updates from CMS as implementation details for both programs may be refined as launch dates approach